At any given time, there are approximately 1,200 clinical trials taking place at Massachusetts General Hospital, the largest hospital-based research enterprise in the United States.
Mass General conducts innovative clinical trials and research studies to increase the understanding of health and disease and advance the fields of medicine and clinical care. We invite patients and the community to participate in clinical trials for access to a wide variety of promising new diagnostics and therapies.
Latest Mass General Clinical Trials
Effects of Transcranial Direct Current Stimulation (tDCS) and Transcranial Ultrasound (TUS) on the perception of pain and functional limitations due to Osteoarthritis of the Knee
The purpose of this research is to determine if transcranial direct current stimulation (tDCS) combined with transcranial ultrasound (TUS) can reduce pain caused by Osteoarthritis of the knee.
Elevations in a hormone may be linked to abnormal blood flow, inflammation, and plaque in the heart. This study will evaluate whether blocking the hormone will improve cardiovascular disease in HIV individuals using heart imaging studies.
POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS with SIGNIFICANT CAROTID ARTERY DISEASE. (The ROADSTER 2 Study)
We are conducting a study to treat patients with significant narrowing of the carotid artery who are at high risk for carotid endarterectomy. The FDA approved ENROUTE Transcarotid Stent & Neuroprotection System will be used for treatment
A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JK07 in Subjects with Heart Failure with Reduced Ejection Fraction (HFrEF)
Adults aged 18 to 80 years old with heart failure are invited to participate in this study. We are looking to evaluate the safety, tolerability, and effects of JK07 on the heart, a drug designed to improve cardiac function.